文献速递中枢神经肿瘤放疗

恶性胶质瘤患者的甲状腺功能减退与性腺功能减退是否具有临床意义:一项胶质瘤患者的纵向试验

Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma.
PubMed 文献 · Radiother Oncol · 2018-10-30

这项单中心纵向试验检测了436例高级别胶质瘤患者在放化疗前、结束时及随访中的下丘脑-垂体激素水平。约10%患者在随访前6个月内出现甲状腺激素水平降低,36个月后增多;绝经前女性半数提前绝经、35%出现高泌乳素血症;50岁以下男性37%、50岁及以上男性35/63(55%)睾酮水平降低。作者认为相当比例患者出现激素缺乏,需定期临床随访、规范咨询及必要时替代治疗。

要点

  • 436例高级别胶质瘤患者中约10%在随访前6个月内出现甲状腺激素水平降低,36个月后增多。
  • 入组时绝经前女性中半数提前绝经,35%出现高泌乳素血症。
  • 50岁以下男性37%、50岁及以上男性35/63(55%)测得睾酮水平降低。

核心结论

  • 作者认为相当比例的恶性胶质瘤患者会出现激素缺乏,需定期临床随访、规范咨询及必要时替代治疗。

研究设计与样本

  • 单中心纵向试验纳入436例高级别胶质瘤患者(198例女性、238例男性),年龄19-83岁(中位50岁)。
  • 在放化疗开始前、放化疗结束时检测TSH、T3、T4、fT3、fT4、FSH、LH、睾酮、雌二醇和催乳素,新诊断患者此后每三个月检测一次,入组前诊断超过两年的患者每六个月检测一次。
  • 本试验未检测生长激素。

主要发现

  • 约10%患者在随访前6个月内观察到甲状腺激素水平降低,36个月后增多。
  • 入组时绝经前女性中半数提前绝经,35%出现高泌乳素血症。
  • 50岁以下男性37%测得睾酮水平降低,50岁及以上男性35/63(55%)测得睾酮水平降低。

临床怎么用

  • 作者认为需定期临床随访、规范咨询,并在临床必要时进行替代治疗。

局限性

  • 本试验为单中心纵向试验。
  • 本试验未检测生长激素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: So far, the development and course of therapy-induced deficiencies in hypothalamic-pituitary hormones in adult patients with malignant gliomas has not received much attention. However, such deficiencies may impact patient's quality of life substantially. METHODS: In this monocentric longitudinal trial, we examined hormonal levels of TSH, T3, T4, fT3, fT4, FSH, LH, testosterone, estradiol and prolactin in patients with malignant high grade gliomas before the start of radiochemotherapy (RCT), at the end of RCT and then every three months for newly diagnosed patients and every six months in patients diagnosed more than two years before study inclusion. Growth hormone was not measured in this trial. RESULTS: 436 patients (198 female, 238 male) with high-grade gliomas, aged 19-83 years (median 50 years), were included in this study. Low levels of thyroid hormones were observed in around 10% of patients within the first six months of follow up and increasingly after 36 months. Half of premenopausal women at study entry developed premature menopause, 35% showed hyperprolactinemia. Low testosterone levels were measured in 37% of men aged less than 50 years and in 35/63 (55%) of men aged 50 years or older. DISCUSSION: The results of this study show that a significant percentage of patients with malignant gliomas develop hormonal deficiencies mandating regular clinical follow up, state of the art counseling and if clinically necessary substitution therapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Handisurya A, Rumpold T, Caucig-Lütgendorf C, et al. Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma. Radiother Oncol. 2018. PMID: 30389240. doi:10.1016/j.radonc.2018.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。